ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 245 filers reported holding ISIS PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 2.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $3,428,000 | -37.2% | 84,802 | -10.7% | 0.01% | -33.3% |
| Q2 2015 | $5,461,000 | +15.7% | 94,960 | +28.0% | 0.01% | 0.0% |
| Q1 2015 | $4,722,000 | +18.1% | 74,192 | +14.5% | 0.01% | +28.6% |
| Q4 2014 | $3,997,000 | +77.0% | 64,776 | +11.3% | 0.01% | +75.0% |
| Q3 2014 | $2,258,000 | +24.9% | 58,176 | 0.0% | 0.00% | +33.3% |
| Q2 2014 | $1,808,000 | +156.8% | 58,176 | +165.3% | 0.00% | +200.0% |
| Q1 2014 | $704,000 | +95.6% | 21,927 | +201.2% | 0.00% | 0.0% |
| Q4 2013 | $360,000 | -61.6% | 7,280 | -70.9% | 0.00% | -50.0% |
| Q3 2013 | $938,000 | +25.7% | 25,009 | -9.9% | 0.00% | +100.0% |
| Q2 2013 | $746,000 | – | 27,763 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 5,729,426 | $364,793,000 | 10.87% |
| DOWLING & YAHNKE LLC | 676,323 | $43,061,000 | 5.38% |
| WILLIAM HARRIS INVESTORS INC | 229,887 | $14,638,000 | 3.84% |
| Opus Point Partners Management, LLC | 60,912 | $3,878,000 | 3.25% |
| Nepsis Inc. | 64,580 | $4,112,000 | 2.48% |
| Private Capital Advisors, Inc. | 106,320 | $6,769,000 | 2.46% |
| PINNACLE ASSOCIATES LTD | 1,889,017 | $120,274,000 | 2.24% |
| MESSNER & SMITH THEME VALUE INVESTMENT MANAGEMENT LTD /CA/ | 20,947 | $1,333,000 | 1.90% |
| Apex Capital Management | 928,654 | $59,127,000 | 1.39% |
| Bellevue Asset Management AG | 147,000 | $9,359,000 | 1.31% |